Our team

Meet Our Experienced Team

Our management team and Scientific Advisory Board bring decades of experience and cutting-edge knowledge to the forefront of TRK receptor research. Collectively, we are dedicated to discovering and developing new therapies that will change the world of oncology, dermatology, and more.

Leadership Team

Kollol Pal, PhD, MBA

Co-Founder & CEO

Jordan Leef

Co-Founder, CBO & CFO

Vlad Coric, MD


Jay Birnbaum, PhD

Vice President, Dermatology

Arthur DeCillis, MD

Senior Medical Advisor, Oncology Portfolio

John Childs, MBA


Brian Lestini, MD, PhD

Chief Medical Officer

W. Robert Bishop, PhD

Vice President, Cancer Biology

Palaniappan Kulanthaivel, PhD

Vice President, Clinical Pharmacology

Vijaypal Reddy, DVM, PhD, DABT

Vice President, Nonclinical Safety

Jeffrey Wasserman, JD

General Counsel

Scientific Advisory Board

Ethan Lerner, MD, PhD

Associate Professor, Dermatology, Harvard Medical School

Karen Lackey

CEO & Co-Founder Centaur Biosciences

Lara Wine Lee, MD, PhD

Assistant Professor, Dermatology, MUSC

Moses Chao, PhD

Professor, Cell Biology, NYU School of Medicine

Timothy Cloughsey, MD

Director, Neuro-Oncology Program, UCLA Medical Center

Want to know more? Contact us today.